Nature Communications (Sep 2021)

Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines

  • Oya Kuseyri Hübschmann,
  • Gabriella Horvath,
  • Elisenda Cortès-Saladelafont,
  • Yılmaz Yıldız,
  • Mario Mastrangelo,
  • Roser Pons,
  • Jennifer Friedman,
  • Saadet Mercimek-Andrews,
  • Suet-Na Wong,
  • Toni S. Pearson,
  • Dimitrios I. Zafeiriou,
  • Jan Kulhánek,
  • Manju A. Kurian,
  • Eduardo López-Laso,
  • Mari Oppebøen,
  • Sebile Kılavuz,
  • Tessa Wassenberg,
  • Helly Goez,
  • Sabine Scholl-Bürgi,
  • Francesco Porta,
  • Tomáš Honzík,
  • René Santer,
  • Alberto Burlina,
  • H. Serap Sivri,
  • Vincenzo Leuzzi,
  • Georg F. Hoffmann,
  • Kathrin Jeltsch,
  • Daniel Hübschmann,
  • Sven F. Garbade,
  • iNTD Registry Study Group,
  • Angeles García-Cazorla,
  • Thomas Opladen

DOI
https://doi.org/10.1038/s41467-021-25515-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Inherited disorders of neurotransmitter metabolism represent a group of rare neurometabolic diseases characterized by movement disorders and developmental delay. Here, the authors report a standardized evaluation of a registry of 275 patients from 42 countries, and highlight an evolving phenotypic spectrum of this disease group and factors influencing diagnostic processes.